相关实验视频

Updated: Jul 9, 2025

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

从免疫突触中排除PD-1:一种调节T细胞功能的新策略

Luke Yi Hao, Shalom Lerrer, Ruijiang Song

bioRxiv : the preprint server for biology

|November 28, 2023

概括

抗PD-1抗体通过将PD-1从免疫突触中移除,促进T细胞激活来增强癌症治疗. 这种机制提供了一个新的治疗策略,超出了简单的连接体阻断.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
在瘤学瘤学.

背景情况:

针对PD-1的免疫检查点抑制剂在癌症治疗中至关重要.
目前的治疗方法阻断了PD-1/连接体相互作用,但只对一小部分患者有益.
抗PD-1抗体作用的确切机制需要进一步阐明.

研究的目的:

在抗PD-1抗体治疗期间调查PD-1在免疫突触中的亚细胞局部化.
确定PD-1从免疫突触中去除是否与T细胞激活相关.
在临床前癌症模型中,比较完整的抗PD-1抗体与碎片抗体的疗效.

主要方法:

在免疫突触中探索PD-1局部化.
评估T细胞激活标记物对抗PD-1抗体的反应.
在综合性瘤模型中对全长和F(ab') 2抗PD-1抗体进行比较分析.

主要成果:

抗PD-1抗体诱导PD-1从免疫突触中去除,而不仅仅是连接体阻塞.
删除PD-1突触与增强的T细胞激活有很强的相关性.
完整的抗PD-1抗体在体内显示出与F(ab') 2片段相比具有更高的抗瘤疗效.

结论:

抗PD-1抗体通过物理地将PD-1从免疫突触中重新安置来激活T细胞.
在突触内调节免疫受体局部化是癌症免疫治疗的可行策略.
这一发现为开发更有效的癌症治疗开辟了新的途径.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

相关概念视频

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.